QLTI

QLT Inc. News Headlines

$6.12
*  
0.22
 negative 
3.73%
Get QLTI Alerts
*Delayed - data as of Apr. 24, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    QLTI After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

QLT Inc. (QLTI) is now in Oversold Territory - Tale of the Tape
3/14/2014 7:56:01 AM - Zacks.com

QLT Narrows Loss in Q4 - Analyst Blog
3/4/2014 11:00:01 AM - Zacks.com

QLT Reports Positive Prelim. Results In Phase 1b Retreatment Trial Of QLT091001
2/27/2014 8:01:00 AM - RTT News

QLT Inc. (QLTI): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/21/2014 8:00:01 AM - Zacks.com

3 Approaches To Retinitis Pigmentosa
1/2/2014 10:36:00 AM - Seeking Alpha

Update from QLTI, Shares up - Analyst Blog
11/21/2013 12:30:01 PM - Zacks.com

QLT (QLTI) Surges: Stock Moves 11.8% Higher - Tale of the Tape
11/21/2013 9:05:29 AM - Zacks.com

Narrower Loss at QLT in Q2 - Analyst Blog
8/5/2013 10:08:18 AM - Zacks.com

QLT Inc. (QLTI) Ex-Dividend Date Scheduled for June 28, 2013
6/27/2013 9:00:05 AM - NASDAQ.com News

QLT Narrows Loss - Analyst Blog
5/7/2013 10:50:01 AM - Zacks.com

Forest Labs' Earnings Decline - Analyst Blog
4/23/2013 3:10:01 PM - Zacks.com

Eli Lilly in Alzheimer's Deal - Analyst Blog
4/22/2013 4:11:11 PM - Zacks.com

Elan Turns Down Royalty's Offer - Analyst Blog
4/22/2013 1:12:28 PM - Zacks.com

Elan's Strike Price Stands at $11.25 - Analyst Blog
4/19/2013 5:13:49 PM - Zacks.com

PCYC Completes RESONATE Enrollment - Analyst Blog
4/19/2013 3:30:01 PM - Zacks.com

Positive Data on Forest Candidate - Analyst Blog
4/18/2013 4:10:18 PM - Zacks.com

Data on Pacira's Exparel - Analyst Blog
4/17/2013 5:11:11 PM - Zacks.com

Elan Responds to Royalty Pharma Offer - Analyst Blog
4/16/2013 5:40:01 PM - Zacks.com

ImmunoGen to Focus on Pipeline - Analyst Blog
4/15/2013 7:05:01 PM - Zacks.com

Good News for Warner Chilcott - Analyst Blog
4/15/2013 5:50:01 PM - Zacks.com

Pharmacyclics Earns 4th Milestone - Analyst Blog
4/15/2013 1:11:40 PM - Zacks.com

UTHR to Move PAH Drug into Phase I - Analyst Blog
4/15/2013 12:11:40 PM - Zacks.com

Repros Gets Additional Patents - Analyst Blog
4/12/2013 5:09:02 PM - Zacks.com

A Look at LLY's Early Stage Oncology Pipeline - Analyst Blog
4/12/2013 3:50:01 PM - Zacks.com

QLT Inc. Enters Oversold Territory - Tale of the Tape
4/12/2013 12:08:01 PM - Zacks.com